Navigation Links
Scientists discover previously unidentified gene key to melanoma progression

San Francisco, CA (PRWEB) February 25, 2015

The mainstay of targeted therapy for melanoma, BRAF inhibitors, has significantly improved the survival of patients with advanced stages of the illness. But resistance to therapy develops in most patients, causing them to stop therapy or switch to another agent. Multiple mechanisms have been proposed that may govern resistance to BRAF inhibitors.

However, whether patients can continue to benefit from targeted therapies has been unclear—until now, with findings uncovered about the previously unidentified gene bromodomain PHD finger transcription factor (BPTF), and its role in tumor development and resistance to therapy. The study was published online today in the Journal of the National Cancer Institute.

“This is the first evidence of the potent role played by BPTF in promoting tumor progression, and of its potential as a molecular diagnostic and prognostic marker,” said Mohammed Kashani-Sabet, MD, Director of the California Pacific Medical Center (CPMC) Center for Melanoma Research and Treatment, Senior Scientist at CPMC’s Research Institute, and senior author of the study.

In the study, Dr. Kashani-Sabet and colleagues at CPMC and the Veterans Affairs Medical Center explored the functional and biological significance of BPTF—known to be important to the remodeling of genetic material and in the developing brain.

The researchers used RNA interference to block the effects of BPTF in several melanoma cells lines, and then assessed the effects on key measures of cancer growth and metastasis. The gene’s functional role was investigated using an animal model of melanoma progression, and tissues from melanoma patients were examined for BPTF’s role as a prognostic biomarker. Levels of the gene were analyzed in tumor samples from eight patients with metastatic melanoma before and after therapy with two commonly used BRAF-inhibitors, vemurafenib and dabrafenib.

Results showed that silencing BPTF significantly suppressed the proliferative capacity and metastatic potential of melanoma cells by two thirds. Suppressing BPTF increased the cells’ sensitivity to BRAF inhibitors, whereas overexpression of BPTF promoted resistance to these drugs. Elevated BPTF copy number was observed in 28 of 77 (36.4%) melanomas. In a cohort of 311 melanoma patients, BPTF over-expression predicted poor survival (distant metastasis-free survival, p=0.03, and disease-specific survival p=0.008), and promoted resistance to BRAF inhibitors in melanoma cell lines.

“Surprisingly, when we examined the tumors of patients who had progressed on anti-BRAF therapy, they were composed of two groups of cells: those that showed no BPTF expression (indicating response to therapy), while other clones of cells had high BPTF expression (suggesting BRAF-resistant cells),” said Dr. Kashani-Sabet, noting the novel finding of intra-tumor molecular heterogeneity. “In contrast, examining tumors from these patients before treatment showed uniform expression of BPTF.”

“Our results suggest that treatment with selective BRAF inhibitors may potentially be continued following the development of resistance, as part of combination therapy. In addition, BPTF-targeting may be a new approach to overcome resistance to BRAF inhibitors, including possible combination treatment for BRAF-mutant melanoma.”

This year alone, more than 76,000 people will be diagnosed with melanoma in the U.S.

The study was supported by United States Public Health Service Grants and by the Mary R. and Joseph R. Payden Foundation.

Read the full story at

Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. Scientists at Cancer Prevention Institute of California Find That a Diet High in Fruits and Vegetables May Significantly Reduce Risk of Breast Cancer
2. Volunteers join scientists in finding out who gets rid of cow dung
3. A*STAR scientists uncover potential drug target to nip cancer in the bud
4. CNIO scientists decipher how the immune system induces liver damage during hepatitis
5. NSF International Scientists Announce Discovery of New Bacterium, Same Family as E. coli and Klebsiella Pneumonia
6. A*STAR scientists bring to light mechanism of drug for infections
7. Scientists fingerprint single cancer cells to map cancers family tree
8. Renowned Scientists Join Cure Alzheimer’s Fund’s Search for Alzheimer’s Therapies
9. LSUHSC faculty shares inside knowledge in book to develop nations research scientists
10. Scientists far from finish line in understanding anemia in female athletes
11. Scientists show how cells protect their DNA from catastrophic damage
Post Your Comments:
(Date:9/1/2020)... ... September 01, 2020 , ... Board certified plastic surgeon Sepideh ... office will be the first to bear her name, Dr. Saber has regularly ... lift), as well as rhinoplasty, facial rejuvenation, and many more in association with ...
(Date:9/1/2020)... ... September 01, 2020 , ... ... specialty fellowship training in aesthetic surgery of the face, breast, and body. In ... only female-owned premier boutique plastic surgery and aesthetic practice in Southwest Florida. Dr. ...
(Date:8/31/2020)... ... August 31, 2020 , ... Ocean Springs, Mississippi-based ... to medical first responders across the United States. Since the start of the ... equipment (PPE) medical centers , hospitals , firefighters , and ...
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... ... business support services to dental groups in the United States, today announced the ... community of Beaumont, CA. , Patients will enjoy convenient hours, a comfortable ...
(Date:8/31/2020)... ... August 31, 2020 , ... Dr. Chang has over ... autism and other developmental disabilities, as well as supporting staff in caring for ... autism, school consultation, and staff development. She joined the company in 2015 as ...
Breaking Medicine News(10 mins):
(Date:9/2/2020)... ... September 02, 2020 , ... Rigaku Analytical Devices , ... among industry professionals about successes and challenges of making changes to their organizations’ ... and will take place on October 15, 2020 at 10:00am PDT / ...
(Date:9/1/2020)... ... September 01, 2020 , ... ... Cosmetics and Laser Surgery at the University of Rochester Medical Center, in Upstate ... SkinCare Physicians in Boston, with clinical faculty from the Harvard and Yale Departments ...
(Date:9/1/2020)... ... ... September is National Ovarian Cancer Awareness Month. Ovarian cancer is the 5th deadliest ... reproductive system. The American Cancer Society estimates that in 2020, about 22,000 women ... disease. Throughout the month of September, Women’s Excellence aims to increase understanding of ...
Breaking Medicine Technology: